LUX HEALTH TECH ACQUIS-CL A logo

LUXA

LUX HEALTH TECH ACQUIS-CL A

$10.04

Earnings Summary

Revenue
$0Mn
Net Profits
$4.69Mn
Net Profit Margins
+Inf%
PE Ratio
21.83

Highlights

Revenue:

LUX HEALTH TECH ACQUIS-CL A’s revenue jumped NaN% since last year same period to $0Mn in the Q2 2022. On a quarterly growth basis, LUX HEALTH TECH ACQUIS-CL A has generated NaN% jump in its revenue since last 3-months.

Net Profits:

LUX HEALTH TECH ACQUIS-CL A’s net profit jumped 133.18% since last year same period to $4.69Mn in the Q2 2022. On a quarterly growth basis, LUX HEALTH TECH ACQUIS-CL A has generated -38.25% fall in its net profits since last 3-months.

Net Profit Margins:

LUX HEALTH TECH ACQUIS-CL A’s net profit margin jumped NaN% since last year same period to +Inf% in the Q2 2022. On a quarterly growth basis, LUX HEALTH TECH ACQUIS-CL A has generated NaN% jump in its net profit margins since last 3-months.

PE Ratio:

LUX HEALTH TECH ACQUIS-CL A’s price-to-earnings ratio after this Q2 2022 earnings stands at 21.83.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the LUX HEALTH TECH ACQUIS-CL A post its latest quarter earnings

EPS Estimate Current Quarter
0
EPS Estimate Current Year
0

Highlights

EPS Estimate Current Quarter:

LUX HEALTH TECH ACQUIS-CL A’s earning per share (EPS) estimates for the current quarter stand at 0 - a NaN% jump from last quarter’s estimates.

EPS Estimate Current Year:

LUX HEALTH TECH ACQUIS-CL A’s earning per share (EPS) estimates for the current year stand at 0.

Key Ratios

Key ratios of the LUX HEALTH TECH ACQUIS-CL A post its Q2 2022 earnings

Earning Per Share (EPS)
0.11
Return on Assets (ROA)
-0
Return on Equity (ROE)
0

Highlights

Earning Per Share (EPS):

LUX HEALTH TECH ACQUIS-CL A’s earning per share (EPS) jumped 120% since last year same period to 0.11 in the Q2 2022. This indicates that the LUX HEALTH TECH ACQUIS-CL A has generated 120% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. LUX HEALTH TECH ACQUIS-CL A’s return on assets (ROA) stands at -0.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. LUX HEALTH TECH ACQUIS-CL A’s return on equity (ROE) stands at 0.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2020-09-30
0
-0
-Inf%